Literature DB >> 13240597

Clinical experiences with hypaque sodium 50% in intravenous urography.

R M LOWMAN, H SHAPIRO, H R NEWMAN.   

Abstract

Entities:  

Keywords:  CONTRAST MEDIA; URINARY TRACT/radiography

Mesh:

Substances:

Year:  1955        PMID: 13240597      PMCID: PMC1826089     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Intravenous urographic contrast media; a controlled study of diodrast and neo-iopax.

Authors:  W H MULLEN; C R HUGHES
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1952-12

2.  Clinical evaluation of a concentrated iodine preparation, for intravenous nephrography and pyelography.

Authors:  A W BOHNE; W W CHRISTESON
Journal:  Radiology       Date:  1953-03       Impact factor: 11.105

3.  Routine clinical experiences using urokon sodium 70% in intravenous urography.

Authors:  A A PORPORIS; O C ZINK; H M WILSON; C N BARRY; R ROYCE; D K ROSE
Journal:  Radiology       Date:  1953-05       Impact factor: 11.105

4.  Prevention of reactions in intravenous urography.

Authors:  S W SIMON; H I BERMAN; S A ROSENBLUM
Journal:  J Allergy       Date:  1954-09

5.  Excretory urography: a clinical trial of a new contrast medium (sodium 3-acetylamino-2,4, 6-triiodobenzoate).

Authors:  L L ROBBINS; F H COLBY; J L SOSMAN; W R EYLER
Journal:  Radiology       Date:  1951-05       Impact factor: 11.105

6.  The experimental and clinical investigation of various media used in translumbar aortography.

Authors:  W F MELICK; J E BYRNE; T D BOLER
Journal:  J Urol       Date:  1952-06       Impact factor: 7.450

7.  Clinical evaluation of urokon in pyelography.

Authors:  J F RICHARDSON; D K ROSE
Journal:  J Urol       Date:  1950       Impact factor: 7.450

8.  Biochemical studies on urokon (sodium 2,4,6-triiodo-3-acetylaminobenzoate) a new pyelographic medium.

Authors:  D H NEUHAUS; A A CHRISTMAN; H B LEWIS
Journal:  J Lab Clin Med       Date:  1950-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.